TLCM
PACB icon

Twin Lakes Capital Management’s Pacific Biosciences PACB Stock Holding History

Twin Lakes Capital Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.48K Sell
5,669
-5,888
-51% -$10.5K ﹤0.01% 190
2025
Q4 		$21.6K Hold
11,557
– – 0.01% 172
2025
Q3 		$14.8K Hold
11,557
– – 0.01% 179
2025
Q2 		$14.3K Hold
11,557
– – 0.01% 174
2025
Q1 		$13.6K Hold
11,557
– – 0.01% 177
2024
Q4 		$21.1K Sell
11,557
-2,713
-19% -$5.3K 0.01% 177
2024
Q3 		$24.3K Hold
14,270
– – 0.02% 171
2024
Q2 		$19.6K Hold
14,270
– – 0.01% 175
2024
Q1 		$53.5K Hold
14,270
– – 0.04% 135
2023
Q4 		$140K Hold
14,270
– – 0.1% 92
2023
Q3 		$119K Hold
14,270
– – 0.09% 98
2023
Q2 		$190K Hold
14,270
– – 0.13% 85
2023
Q1 		$165K Hold
14,270
– – 0.12% 93
2022
Q4 		$117K Hold
14,270
– – 0.09% 101
2022
Q3 		$83K Buy
+14,270
New +$81.9K 0.07% 108
2022
Q2 		– Sell
-14,270
Closed -$130K – 243
2022
Q1 		$130K Buy
14,270
+929
+7% +$10.7K 0.07% 106
2021
Q4 		$273K Hold
13,341
– – 0.15% 86
2021
Q3 		$341K Sell
13,341
-2,454
-16% -$72.7K 0.2% 68
2021
Q2 		$552K Sell
15,795
-3,572
-18% -$104K 0.31% 53
2021
Q1 		$645K Sell
19,367
-989
-5% -$34.6K 0.4% 47
2020
Q4 		$528K Buy
+20,356
New +$346K 0.38% 54

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Twin Lakes Capital Management's PACB Position: Q1 2026 in Review

Twin Lakes Capital Management reduced its Pacific Biosciences (PACB) stake by 51% in Q1 2026, selling an estimated $10.5K and leaving 5,669 shares worth $7.48K. The position accounts for ﹤0.01% of the portfolio, ranked #190.

Twin Lakes Capital Management first reported a position in PACB in Q4 2020 and has held it in 21 quarters since. The position peaked at $645K in Q1 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Twin Lakes Capital Management held 5,669 shares of Pacific Biosciences worth $7.48K as of Q1 2026.
  • Twin Lakes Capital Management sold 5,888 Pacific Biosciences shares in Q1 2026, an estimated $10.5K.
  • Pacific Biosciences made up ﹤0.01% of Twin Lakes Capital Management's portfolio in Q1 2026, its #190 holding.
  • Twin Lakes Capital Management first reported a position in Pacific Biosciences in Q4 2020 and has held it in 21 quarters since.
  • Twin Lakes Capital Management's Pacific Biosciences position peaked at $645K in Q1 2021.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Twin Lakes Capital Management's 13F filing for Q1 2026, filed 18 May 2026.